Table 4.

Analysis of OraQuick ADVANCE Saliva Cross-Reactivity With Blood Tests

HIV-1 Diagnostic Test	Participants Testing Reactive n (%)	P Value vs OraQuick ADVANCE
OraQuick ADVANCE	0 of 120 (0%)	–
Bio-Rad GS	65 of 120 (54%)	<.0001
Abbott Architect	76 of 120 (63%)	<.0001
Alere Determine	58 of 120 (48%)	<.0001
Abbott Prisma	41 of 43 (95%)	<.0001

Abbreviations: HIV, human immunodeficiency virus.

^aAbbott Prism was only used if samples tested negative on all 3 of the fourth-generation antigen/antibody tests (n = 41).